Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy

SIMPLE SUMMARY: Albumin–bilirubin (ALBI) grade is an objective and reproducible model for evaluating overall survival (OS) in patients with hepatocellular carcinoma (HCC). The original ALBI grade was established for patients with Child–Pugh classes A–C. HCC patients with Child–Pugh class C or poor p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Wei-Fan, Hsu, Shih-Chao, Chen, Te-Hong, Lin, Chien-Hung, Lin, Ying-Chun, Chang, Yu-Wei, Wang, Hung-Wei, Liao, Yu-Min, Lai, Hsueh-Chou, Peng, Cheng-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600636/
https://www.ncbi.nlm.nih.gov/pubmed/36291867
http://dx.doi.org/10.3390/cancers14205083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600636/
https://www.ncbi.nlm.nih.gov/pubmed/36291867
http://dx.doi.org/10.3390/cancers14205083

Ejemplares similares